Yilmaz, S. Et Al. 2017. A treatable cause of myelopathy and vision loss mimicking neuromyelitis optica spectrum disorder: late-onset biotinidase deficiency. METABOLIC BRAIN DISEASE , vol.32, no.3 , 675-678.

Yilmaz, S., Serin, M., CANDA, E., ERASLAN, C., Tekin, H., Ucar, S. K., ... GÖKBEN, S.(2017). A treatable cause of myelopathy and vision loss mimicking neuromyelitis optica spectrum disorder: late-onset biotinidase deficiency. METABOLIC BRAIN DISEASE , vol.32, no.3, 675-678.

Yilmaz, Sanem Et Al. "A treatable cause of myelopathy and vision loss mimicking neuromyelitis optica spectrum disorder: late-onset biotinidase deficiency," METABOLIC BRAIN DISEASE , vol.32, no.3, 675-678, 2017

Yilmaz, Sanem Et Al. "A treatable cause of myelopathy and vision loss mimicking neuromyelitis optica spectrum disorder: late-onset biotinidase deficiency." METABOLIC BRAIN DISEASE , vol.32, no.3, pp.675-678, 2017

Yilmaz, S. Et Al. (2017) . "A treatable cause of myelopathy and vision loss mimicking neuromyelitis optica spectrum disorder: late-onset biotinidase deficiency." METABOLIC BRAIN DISEASE , vol.32, no.3, pp.675-678.

@article{article, author={Sanem Yilmaz Et Al. }, title={A treatable cause of myelopathy and vision loss mimicking neuromyelitis optica spectrum disorder: late-onset biotinidase deficiency}, journal={METABOLIC BRAIN DISEASE}, year=2017, pages={675-678} }